Serine protease inhibitors and cytotoxic T lymphocytes

被引:0
|
作者
Ashton-Rickardt, Philip G. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Immunol, London W12 0NN, England
基金
英国惠康基金; 美国国家卫生研究院; 英国医学研究理事会;
关键词
serine protease inhibitors; cytotoxic T cells; apoptosis; GRANZYME-B INHIBITOR; CELLS IN-VIVO; RENAL-ALLOGRAFT REJECTION; PERFORIN-DEFICIENT MICE; MEDIATED CYTOTOXICITY; VIRAL-INFECTION; DENDRITIC CELLS; STEM-CELLS; TRANSCRIPTION FACTOR; INDUCED APOPTOSIS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serine proteases control a wide variety of physiological and pathological processes in multi-cellular organisms, including blood clotting, cancer, cell death, osmoregulation, tissue remodeling, and immunity to infection. Cytotoxic T lymphocytes (CTLs) are required for adaptive cell-mediated immunity to intracellular pathogens by killing infected cells and through the development of memory T cells. Serine proteases not only allow a CTL to kill but also impose homeostatic control on CTL number. Serine protease inhibitors (serpins) are the physiological regulators of serine proteases' activity. In this review, I discuss the role of serpins in controlling the recognition of antigen, effector function, and homeostatic control of CTLs through the inhibition of physiological serine protease targets. An emerging view of serpins is that they are important promoters of cellular viability through their inhibition of executioner proteases. This view is discussed in the context of the T-lymphocyte survival during effector responses and the development and persistence of long-lived memory T cells. Given the important role serpins play in CTL immunity, I discuss the potential for developing new immunotherapeutic approaches based directly on serpins or knowledge gained from identifying their physiologically relevant protease targets.
引用
收藏
页码:147 / 158
页数:12
相关论文
共 50 条
  • [21] Library of serine and cysteine protease inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (03) : 123 - 124
  • [22] A GENERIC APPROACH TO SERINE PROTEASE INHIBITORS
    GLOVER, GI
    SCHASTEEN, CS
    FEDERATION PROCEEDINGS, 1986, 45 (06) : 1858 - 1858
  • [23] Coumarin and isocoumarin as serine protease inhibitors
    Pochet, L
    Frédérick, R
    Masereel, B
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (30) : 3781 - 3796
  • [24] Engineering thermostability in serine protease inhibitors
    Im, H
    Ryu, MJ
    Yu, MH
    PROTEIN ENGINEERING DESIGN & SELECTION, 2004, 17 (04): : 325 - 331
  • [25] A SERINE PROTEASE TRIGGERS THE INITIAL STEP OF TRANSMEMBRANE SIGNALING IN CYTOTOXIC T-CELLS
    UTSUNOMIYA, N
    NAKANISHI, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1986, 261 (35) : 6514 - 6517
  • [26] Dendritic Cells Treated with Lipopolysaccharide Up-Regulate Serine Protease Inhibitor 6 and Remain Sensitive to Killing by Cytotoxic T Lymphocytes In Vivo
    Andrew, Kate A.
    Simkins, Helen M. A.
    Witzel, Sabine
    Perret, Rachel
    Hudson, Jenny
    Hermans, Ian F.
    Ritchie, David S.
    Yang, Jianping
    Ronchese, Franca
    JOURNAL OF IMMUNOLOGY, 2008, 181 (12): : 8356 - 8362
  • [27] QUANTITATION OF SERINE PROTEASE INHIBITORS BY SYNTHETIC PEPTIDE ANALOGS OF SERINE PROTEASE AND BY IMMUNOLOGICAL METHODOLOGIES
    PARVEZ, Z
    MESSMORE, HL
    FAREED, J
    MONCADA, R
    FEDERATION PROCEEDINGS, 1979, 38 (03) : 1063 - 1063
  • [28] A COMPARISON BETWEEN PLASMA SERINE PROTEASE INHIBITORS AND PROTEASE NEXIN
    THOMPSON, JA
    CUNNINGHAM, DD
    CLINICAL RESEARCH, 1984, 32 (01): : A35 - A35
  • [29] Serine kinases and T lymphocytes
    Cantrell, D
    FASEB JOURNAL, 2004, 18 (08): : C6 - C6
  • [30] CYTOTOXIC PROTEASE ISOLATED FROM HUMAN LYMPHOCYTES
    HATCHER, VB
    LAZARUS, GS
    GRAYZEL, AI
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 892 - 892